Search Index

Scientia News is full of STEM blogs, articles and resources freely available across the globe for students. Browse all of our fascinating content written by students and professionals showing their passion in STEM and the other sciences. Log In Welcome to Scientia News DELIVERING INFORMATIVE CONTENT Scientia News is full of STEM blogs, articles and resources freely available across the globe for students. Browse all of our fascinating content written by students and professionals showing their passion in STEM and other sciences. We hope this platform helps you discover something that inspires your curiosity, and encourages you to learn more about important topics in STEM. Meet the Official Team NAVIGATE AND CLICK THE PHOTOS BELOW TO LEARN MORE ABOUT US! To play, press and hold the enter key. To stop, release the enter key. To play, press and hold the enter key. To stop, release the enter key. To play, press and hold the enter key. To stop, release the enter key. Latest Articles neuroscience Does being bilingual make you smarter? View More ecology Meet the microbes that feed phosphorus to plants View More biology Maveerar Naal: health, trauma, and resilience amid decades of war View More physics Creatio ex Nihilo: a Christian creation doctrine including physics View More CONTACT CONTACT US Scientia News welcomes anyone who wants to share their ideas and write for our platform. If you are interested in realising your writing potential with us AND live in the UK; and/ or would like to give feedback: Email us at scientianewsorg@gmail.com or fill in our GET IN TOUCH form below and we'll be in contact... Follow us on our socials for the latest updates. Comment, like and share! Join our mailing list below for latest site content. You can also sign up to become a site member . SUBSCRIPTION Join our mailing list to receive alerts for new articles and other site content. Be sure to check your spam/ junk folders in case emails are sent there. Email Subscribe GET IN TOUCH First Name Last Name Email Message Send Thanks for submitting!

Strategies for success and mathematical mastery Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link How to excel in maths 09/07/25, 14:19 Last updated: Published: 01/10/23, 20:00 Strategies for success and mathematical mastery Mathematics is a subject that can be both daunting and rewarding. While some individuals seem to effortlessly grasp mathematical concepts, most of us need to put in extra effort to excel. This article is dedicated to the majority—the ones willing to work hard to achieve success in their A-level maths exams and beyond. By following a structured approach and embracing a growth mindset, you can unlock your mathematical potential and reach heights you may have never thought possible. Understanding the concepts Fundamentally, to be able to get anywhere in mathematics, you need to understand what you are doing with numbers and why. There is no point in knowing how to differentiate if you don’t know why you want to differentiate and why it works. Now, I am a strong believer that anyone can learn anything if they approach it with an open mind and determination to succeed. This is called having a growth mindset. However, there is a caveat with how maths is taught at school. When maths is taught, it is taught by someone who understands a concept in a particular way. We are all inherently different, and similarly, our minds all work slightly differently. So when your teacher explains how they understand something, it does not mean that you should also understand it as you both think differently. Now for some, they manage to grasp what their teacher is saying easily as they think similarly, but for others this may need an alternative approach. Some examples could be supplementary lessons with a tutor, buying a subscription to online lessons or asking for some 1-on-1 time with your teacher. But sometimes this may still not even work. If my teacher can’t help me, how can I learn? Well, for A-Levels and GCSEs, we are extremely blessed that there is a plethora of different resources that we can use, both written and in video format! Some of my favourites include, but are not limited to, TLMaths (Youtube), BBC Bitesize (GCSE only), and Khan Academy. (Also see: Extra Resources for more maths resources). YouTube really can be your best friend. There are thousands of videos explaining mathematical concepts, and they are not all as trivial as those shared by Numberphile. By simply searching for a topic that you are stuck on, you can get many different professionals to explain the same problem; with enough grit and determination, you’ll be able to find a video that you can easily understand! If, however, that does not seem to work, it may be an indicator that you need to step back and learn the fundamentals a bit better. There is little point in using the integral to calculate the area under a line graph if you don’t know what a line graph actually shows. Practice the concepts Once you’ve got the concepts down to the tee, there is only one option to go with. Practice. Practice. Practice. I foolishly made the mistake during my year 10 final exams, where instead of doing practice questions, I made notes from watching videos and thought that was enough. Not only is this not engaging, but when it comes to maths, practice is the only way to revise. Truthfully, I would never recommend taking notes in maths as it is not only quicker to look something up, but I believe the time spent making notes could be spent better elsewhere. The best way to practice for an exam is through practice papers. You may now be dashing off to find practice papers for your exam board; however, I would recommend not touching these until you are around 1 month away from your exam. If you are as crazy as I am, you could even leave it until the last week and complete 2 or 3 per day, but maybe for your sanity, I’d advise against this. Instead, use all of the resources that you are fortunate enough to have available to you thanks to the internet. Complete every question in your textbook and revision guide; complete predicted papers; do it all! This is the surefire way to get top marks and become a competent mathematician. But maybe you’re not studying for a big A-level exam just yet. By completing the questions that you may not have done in class and researching topic-specific questions (Math’s Genie and Physics and Maths Tutor are both excellent resources for this), you will, with time, start to develop your skills and put the theory into practice. By better applying these concepts, you begin to understand them and maybe even start to enjoy them. (Bonus tip: do your homework. It’s given out for a reason.) Apply the concepts to unfamiliar situations Now that you have mastered the concepts and put them to the test by answering every question you can get your hands on, comes the trickiest part of mathematical mastery: These are the questions that separate the A’s and the A*’s. The geniuses and the sedulous, but more importantly, those who can do maths, and those who understand maths. By applying the mathematical concepts that you’ve learned to unfamiliar situations, you start to develop an extremely sought-after skill. Problem solving. By using maths in an unfamiliar context, most students are hasty to give up, and this is why the last question on the test is so ‘difficult’, but in fact it's the same as the prior questions but in disguise. To conquer these questions, you have to be able to decipher what the question is asking and then apply the appropriate techniques to solve it. The only way that you will know which techniques to use is by attempting similar questions that push you, and in time, your brain's pattern recognition will kick in and you’ll start to find that you just know what to do. You can't explain it; you just want to differentiate here, factor out here, and expand these brackets here, and bam! You’ve got the answer. But the only way you can get there is by putting in the hours and attempting questions that are outside your comfort zone. At the beginning of the article, I said it would be tough, but maths does not require you to spend 4 hours every night (until you are smack in the middle of your A-level exams), but instead a mere 20 minutes, maybe only 5 days a week, but I promise you that this small amount of time after school, before bed, or during break, if uninterrupted and follows the rules that I have just suggested, will work absolute wonders on your mathematical ability. Imagine the impact of dedicating just 20 minutes a day to math starting right now. If you're in year 13, with your first math paper 38 weeks away on June 4th, time will fly. By committing to 20 minutes daily, five days a week, you'll accumulate over 63 hours of revision. Bump it up to half an hour, and you'll hit almost 100 hours. This early start saves you precious time closer to exams, allowing you to focus on other subjects. Unlike some subjects, math doesn't require rote memorisation. Building these skills gradually pays off. Yes, 20 minutes daily may seem modest, but consistency can be challenging. Skipping just one day can turn into a week, then a month. Dedication, determination, and discipline are essential for success. If you maintain this routine, you can achieve remarkable results, even surpassing natural mathematical geniuses. Now with the three steps to mathematical freedom: Understand the concepts. Practice the concepts. Apply the concepts to unfamiliar situations. Go out there and give it your best shot! I wish you all the best of luck in your journey to mathematical mastery! Written by George Chant Related articles: The game of life / Teaching maths / Topology Project Gallery

Uncovering the truth behind the origins of the virus Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Origins of COVID-19 10/07/25, 10:27 Last updated: Published: 08/10/23, 16:07 Uncovering the truth behind the origins of the virus The quest for the crime of the century begins now! Suspicion of the Wuhan Institute of Virology Since the early epidemic reports in Wuhan, the origin of COVID-19 has been a matter of contention. Was SARS-CoV-2 the outcome of spontaneous transmission from animals to humans or scientific experimentation? Although most of the recorded initial cases occurred near a seafood market, Western Intelligence Agencies knew that the Wuhan Institute of Virology (WIV) was situated nine miles to the south. Researchers at the biosafety centre combed Yunnan caves for bats harbouring SARS-like viruses. They have been extracting genetic material from their saliva, urine, and faeces. Additionally, bat coronavirus RaTG13 (BatCoV RaTG13) shared 96% of its genome with SARS-CoV-2. Suspicion increased when it was discovered that WIV researchers dealt with chimeric versions of SARS-like viruses capable of infecting human cells. However, similar "gain-of-function" studies in Western biosecurity institutions have shown that such slow virulence increases may occur naturally. The coincidence that the pandemic began in the same city as the WIV outbreak was too obvious to ignore. According to two Chinese specialists , "the likelihood of bats flying to the market was quite remote". Chan and Ridley's "Quest for the Origin of COVID-19" Chan and Ridley have created a viral whodunit titled "Quest for the origin of COVID-19" to excite the curiosity of armchair detectives and scientific sceptics. Both need clarification as to why a virus of unknown origin was detected in Wuhan and not in Yunnan, 900 kilometres to the south. The stakes could not be more significant; if the virus were deliberately developed and spread by a Chinese laboratory, it would be the crime of the century. They are prudent in not going that far. They are, however, within their rights to cast doubt on the findings since their concerns were shared by numerous coronavirus experts who openly discounted the possibility of a non-natural origin and declared that the virus displayed no evidence of design at the time. Is this the impartial and fair probe the world has been waiting for? They present no evidence for the development of SARS-CoV-2. For example, Chan asserts that it seemed pre-adapted to human transmission " to an extent comparable to the late SARS-CoV-2 outbreak ". This statement is based on a single spike protein mutation that appears to "substantially enhance" its potential to connect to human receptor cells, meaning it had "apparently stabilised genetically" when identified in Wuhan. Nonetheless, this is a staggeringly misleading statement. As seen by the alphabet soup of mutations, the coronavirus has undergone multiple alterations that have consistently increased its suitability. Additionally, viruses isolated from pangolins attach to human receptor cells more efficiently than SARS-CoV-2, indicating the possibility of additional adaptation. According to two virologists, although the SARS-CoV-2 virus was not wholly adapted to humans, it was "merely enough". Evidence for design of SARS-CoV-2 and possible natural origins of the virus Another concerning feature of SARS-CoV-2 is a furin cleavage site, which enables it to infect human cells by interfering with the receptor protein. The identical sequence is present in highly pathogenic influenza viruses and was previously utilised to modify the spike protein of COVID-19. Chan and Ridley explain that this is the kind of insertion that would occur in a laboratory-modified bat virus. As a result, 21 leading experts have concluded that the furin sequence is insufficient. Coronaviruses have been shown to possess " near identical " genomes that often can infect humans and animals. Because the furin cleavage site characteristic is not seen in known bat coronaviruses, it is possible that it evolved naturally. Surprisingly, Chan and Ridley do not suggest that the SARS virus's high human infectivity feature was inserted on purpose since "there is no way to determine". There is also no way to determine if a RaTG13 is the pandemic virus's progenitor since history is replete with pandemics that began with zoonotic jumps. This argument is based on the strange fact that WIV researchers retrieved the bat isolate in 2013 from a decommissioned mine shaft in Yunnan. Six people were removing bat guano from the cave that year when they suffered an unexplained respiratory ailment. As a consequence, half of them perished. The 4% genetic diversity between RaTG13 and SARS-CoV-2, on the other hand, is similar to 40 years of evolutionary change. While exploring caves in northern Laos, researchers discovered three more closely related bat coronaviruses, which have a higher affinity to attach to human cells than the early SARS-CoV-2 strains. This indicates an organic origin, either through another animal host or directly from a bat, maybe when a farmer went into a cave. This is arguably the most reasonable explanation since it is consistent with forensic and epidemiological data. The food sample isolates collected from the Wuhan seafood market are similar to human isolates, and the majority of original human cases had a history of market exposure, in contrast to the absence of an epidemiological connection to the WIV or any other Wuhan research institution. Lack of evidence for a laboratory origin If scientists could demonstrate prior infection at the Wuhan market or other Chinese wildlife markets that sell the most likely intermediary species, including pangolins, civet cats, and raccoon dogs, the case for a natural origin would be strengthened. Although multiple animals tested positive for sister human viruses during the SARS epidemic, scientists have yet to find evidence of earlier infections in animals in the instance of Sars-CoV-2. Nonetheless, the absence of evidence does not confirm the absence and may indicate that samples were not taken from the appropriate animal. The same may be said of the lab leak argument's lack of evidence. However, even though history is littered with pandemics, no significant pandemic has ever been traced back to a laboratory. In other words, the null hypothesis is a zoonotic occurrence; Chan and Ridley must demonstrate otherwise. The irony is their drive to construct a compelling case for a laboratory accident. They are oblivious to the much more pressing story of how the commerce in wild animals, global warming, and habitat degradation increase the likelihood of pandemic viral development. This is the most plausible origin story that should concern us. Summary Although Chan and Ridley's "Quest for the Origin of COVID-19" has cast suspicion on the Wuhan Institute of Virology, there is still insufficient evidence to support the lab leak theory. There is, however, growing evidence for a natural origin of SARS-CoV-2, with multiple animals testing positive for sister human viruses during the SARS epidemic and the discovery of more closely related bat coronaviruses in northern Laos. As such, we should be more concerned with the increasing likelihood of pandemic viral development due to the commerce in wild animals, global warming, and habitat degradation. Written by Sara Maria Majernikova Project Gallery

Using the new technology AI to develop drugs Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Artificial Intelligence in Drug Research and Discovery 09/07/25, 10:56 Last updated: Published: 24/05/23, 10:20 Using the new technology AI to develop drugs Drug research has been transformed by artificial intelligence (AI), which has become a game-changing technology in several industries. Only a small portion of potential drugs make it to the market after the lengthy and expensive traditional drug discovery process. A drug's discovery and development can take over ten years and cost an average of US$2.8 billion. Even then, nine out of 10 medicinal compounds fall short of passing regulatory approval and Phase II clinical trials. The use of AI in this process, however, has the potential to greatly improve effectiveness, accuracy, and success rates. Given that AI can help with rational drug design, support decision-making, identify the best course of treatment for a patient, including personalised medicines, manage the clinical data generated, and use it for future drug development, it is reasonable to assume that it will play a role in the development of pharmaceutical products from the laboratory bench to bedside table. There are several ways in which AI is currently being used to enhance the drug discovery process. One of the primary applications is virtual screening ( Figure 2 ), which involves using machine learning algorithms to analyse large libraries of chemical compounds and predict which ones are likely to be effective against a specific disease target. This can significantly reduce the time and cost required for drug discovery by narrowing down the number of compounds that need to be tested in the lab. Another way AI is being used in drug discovery is through generative models, which use deep learning algorithms to design molecules that are optimised for specific therapeutic targets. This approach can be used to design molecules that are effective against a specific target while also minimising toxicity or other undesirable properties. Data analysis is another area where AI can be applied in drug discovery. By analysing large datasets of biological and chemical information, AI can help researchers identify patterns and relationships that may be relevant to drug discovery. For example, AI can be used to analyse genomic data to identify potential drug targets or to analyse drug-drug interactions to identify potential safety issues. However, one of the main challenges is the need for high-quality data, as AI models rely on large amounts of data to make accurate predictions. Additionally, there is a risk that AI models may miss important insights or make incorrect predictions if the data used to train them is biased or incomplete. Nevertheless, the continued development of AI and its amazing tools seeks to lessen the difficulties experienced by pharmaceutical firms, impacting both the medication development process and the full lifecycle of the product, which may account for the rise in the number of start-ups in this industry. The importance of automation will increase as a result of using the most up-to-date AI-based technologies, which will not only shorten the time needed for products to reach the market but also enhance product quality, increase overall production process safety, and make better use of available resources while also being cost-effective. In conclusion, the use of AI in drug discovery has the potential to revolutionize the field and significantly improve the success rate of potential drug candidates. Despite the challenges and limitations, the continued research and development of AI in drug discovery will undoubtedly lead to faster, cheaper, and more accurate drug development. Written by Navnidhi Sharma Related articles: A breakthrough procedure in efficient drug discovery / AI in medicinal chemistry / AI advancing genetic disease diagnosis Project Gallery

Using Surface Guided Radiation Therapy (SGRT) Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Revolutionising patient setup in cancer treatment 11/07/25, 09:50 Last updated: Published: 18/10/23, 10:50 Using Surface Guided Radiation Therapy (SGRT) Cancer treatment can be a painstaking and difficult procedure to undergo given the complexity in the treatment process. The weight of a cancer diagnosis carries a huge mental and physical burden on the patient. It is therefore important to place emphasis on delivering an efficient and streamlined process whilst at the same time not cutting any corners. Manual methods of delivering care can and should be automated by AI and technology where possible. This is especially applicable in the preparation of delivering a dose of radiotherapy treatment where traditionally, breast cancer patients will undergo a tattoo setup which provides physical guidance on area at which the dose should be delivered. Patients suffer not only by the knowledge of the disease, but they are also marked with reminders of the experience by an increasingly outdated positioning technique. Innovation in radiotherapy treatment allows for a more ethical and streamlined solution. Surface Guided Radiation Therapy (SGRT) treatments provide a means for tracking a patient's position before and during radiation therapy, to help ensure a streamlined workflow for accurate treatment delivery. This type of treatment not only eliminates the need for an invasive tattoo setup but also provides a faster and more accurate way to deliver radiation doses to the patient. For example, precise measurements made by the software will ensure that radiation is delivered specifically to the targeted area and not the surrounding tissue. With a regular tattoo setup, this can be a common issue as patient movement, often triggered by respiration, can alter the accuracy of the tattoo markup, thereby reducing the effectiveness of the radiation treatment. The way in which many SGRTs work is through a system of cameras, mounted to the ceiling, which feed data into a software program. Each camera unit uses a projector and image sensors to create a 3D surface model of the area by projecting a red light onto the patient’s skin. (See Figure 2) This 3D surface model serves as a real-time map of the patient's position and surface contours. By constantly comparing the captured data with the pre-defined treatment plan, any deviations or movements can be detected instantly. If the patient moves beyond a predetermined threshold, the treatment can be paused to ensure accuracy and safety. The use of this cutting-edge technology is an important step in being able to provide some level of comfort for patients in a challenging environment. The integration of such systems represents a significant advancement in patient-centric care in the field of radiation therapy. Written by Jaspreet Mann Related article: Nuclear medicine Project Gallery

Testing cancerous tumours Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A new tool to diagnose: liquid biopsies 08/07/25, 16:15 Last updated: Published: 15/01/24, 23:48 Testing cancerous tumours Liquid biopsies are an example of integrating next-generation sequencing to diagnose and study tumours using only blood or other fluid samples rather than solid tissue. These biopsies are significant in modern medicine, particularly in treating cancer, as they enable the earlier detection of cancers in a less invasive manner. In this article, I aim to explore liquid biopsies, their role in disease detection and issues which arise from their usage. A liquid biopsy is a test which detects cancerous tumours from the pieces of tumour that break off and circulate in the bloodstream. A liquid biopsy involves a simple blood test and analysis in the lab with a machine that separates blood cells from the plasma, allowing a pathologist to examine the fluid and look for biomarkers. These include circulating tumour cells (CTC) or circulating tumour DNA (ctDNA). CTCs are cancer cells that disseminate from a tumour and travelling in the bloodstream, whereas ctDNA is a DNA fragment from the tumour circulating in the blood. See Figure 1 for a diagram summarising this process in more detail. Finding these biomarkers shows evidence of a malignant tumour, possibly revealing its stage of development and potential metastases. Oncologists use this information to form the basis of cancer prognosis. Furthermore, genetic data from these tests provides information on suitable and effective treatments specific to the patient. In particular, the suitability for targeted therapies, which target specific genes or proteins within the cancer. Furthermore, it can monitor how well a treatment is working by seeing if the tumour has stopped growing after treatment. Finally, it can be used to predict and help prevent recurrence of cancer or progression of cancer by detecting minimal residual disease (where a small number of cancer cells remain in the body after treatment). Liquid biopsies are perhaps better and more advantageous than normal biopsies, as the method is quicker without requiring surgical intervention. In addition, liquid biopsies provide a more comprehensive tissue profile by taking tumour heterogeneity into account. This includes revealing more information about genetic variations, monitoring clonal evolution, assessing treatment resistance, and aiding in the customisation of targeted therapies. This means a more comprehensive view is provided compared to tissue biopsies, which do not represent the entire genetic diversity of a tumour. Liquid biopsies excel in overcoming these limitations by providing a systematic and dynamic assessment of the entire tumour’s genetic diversity. Unlike tissue biopsies, which may miss subclones, liquid biopsies offer a more comprehensive understanding of the overall tumour, making them a valuable tool for precision oncology. The process is also minimally invasive and only causes minimal pain. While liquid biopsies offer a less invasive means of monitoring diseases, their sensitivity and specificity in detecting biomarkers, such as circulating tumour DNA (ctDNA) or circulating tumour cells (CTCs), might vary, leading to potential false positives or negatives. Additionally, the quantity and quality of biomarkers present in bodily fluids can fluctuate, impacting the reliability of liquid biopsy results for consistent monitoring. Furthermore, the associated cost of analysing liquid biopsy samples and the technology required for accurate detection can pose financial constraints for widespread implementation in healthcare systems. See Figure 2 which summarises the advantages and disadvantages of each method. Currently, there are a few liquid biopsy tests approved by the FDA to detect cancer within a patient. One example is the “Guardant 360 CDx”, approved for use in people with non-small cell lung cancer (NSCLC). Another example is the “Foundation One liquid CDx”, which is approved for use in people with a range of cancers such as NSCLC, prostate, ovarian and breast cancer. However, more research is needed to clinically evaluate the efficacy of liquid biopsies when compared to tissue biopsies. Nevertheless, liquid biopsies show a positive prospect for cancer diagnosis. Furthermore, liquid biopsies have also been used outside of cancer, such as in cardiovascular conditions such as myocardial infarction. In myocardial infarction, specific miRNA signatures released during myocardial necrosis provide accurate early detection of myocardial infarction. Further highlighting the multilevel potential of liquid biopsies. One of the main ethical concerns surrounding liquid biopsies involves the revealing of sensitive genetic information about a patient, encompassing medical history, and genetic identity, and potentially impacting familial relationships and legal affairs. This raises critical issues regarding privacy, consent, and the secure storage of such sensitive data. Additionally, challenges surrounding standardisation, cost-effectiveness, and the establishment of robust regulatory frameworks for the handling and storage of this genetic information further underscore the ethical complexities and necessity for stringent protocols in the implementation and management of liquid biopsy technologies. To conclude, it is clear that liquid biopsies have a lot of potential in diagnosing patients and, therefore, treating patients by aiding clinical decisions made by healthcare professionals. It has proven to be useful not just in diagnosing cancer but also in cardiovascular conditions such as myocardial infarction. The process has the potential to improve future patient outcomes. However, for this to happen, issues such as costs and ethics must be addressed so that liquid biopsies can be utilised more effectively in clinical practice. Written by Harene Elayathamby References: professional, C.C. medical Liquid biopsy: What it is & procedure details , Cleveland Clinic . Available at: https://my.clevelandclinic.org/health/diagnostics/23992-liquid-biopsy (Accessed: 19 December 2023). A tale of two biopsies: Liquid biopsy vs tissue biopsy (no date) Biochain Institute Inc. Available at: https://www.biochain.com/blog/a-tale-of-two-biopsies-liquid-biopsy-vs-tissue-biopsy/ (Accessed: 19 December 2023). Adhit, K.K. et al. (2023) ‘Liquid biopsy: An evolving paradigm for non-invasive disease diagnosis and monitoring in medicine’, Cureus [Preprint]. doi:10.7759/cureus.50176. Mannelli, C. (2019) ‘Tissue vs liquid biopsies for cancer detection: Ethical issues’, Journal of Bioethical Inquiry , 16(4), pp. 551–557. doi:10.1007/s11673-019-09944-y. Figures: Journey of a liquid biopsy (no date) Diagnostics . Available at: https://diagnostics.roche.com/global/en/article-listing/infographic-journey-of-a-liquid-biopsy.html (Accessed: 19 December 2023). A tale of two biopsies: Liquid biopsy vs tissue biopsy (no date) Biochain Institute Inc. Available at: https://www.biochain.com/blog/a-tale-of-two-biopsies-liquid-biopsy-vs-tissue-biopsy/ (Accessed: 19 December 2023) Project Gallery

Channel-blocking nanoparticles as a potential solution to plant diseases Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The secret to disarming plant pathogens revealed Last updated: 22/09/25, 10:14 Published: 27/03/25, 08:00 Channel-blocking nanoparticles as a potential solution to plant diseases Unravelling the role of bacterial proteins in plant diseases! Disarming plant diseases one protein at a time! Scientists may have found a means to neutralise them, saving farmers $220 billion in yearly crop losses. The impact of plant diseases on global food production Bacteria have long been known to wreak havoc on crops, threatening our food supply and causing substantial economic losses. For over two decades, biologist Sheng-Yang He and his dedicated team have been delving into the mysterious world of bacterial proteins, seeking to unravel their role in plant diseases that plague countless crops worldwide. Finally, a breakthrough has been achieved after years of tireless research and collaboration. In a groundbreaking study published in the esteemed journal Nature, he and his colleagues have uncovered the mechanisms by which these proteins induce disease in plants and devised a method to neutralise their harmful effects. Understanding the mechanism of harmful proteins Their investigation focused on a group of injected proteins called AvrE/DspE, responsible for causing diseases ranging from brown spots in beans to fire blight in fruit trees. Despite their significance, the exact workings of these proteins have long remained elusive. The researchers discovered that these proteins adopt a unique 3D structure resembling a tiny mushroom with a cylindrical stem through cutting-edge advancements in artificial intelligence and innovative experimental techniques. Intriguingly, this structure resembled a straw, leading the team to hypothesise that the proteins create channels in plant cells, enabling the bacteria to extract water from the host during infection. Further investigation into the 3D model of the fire blight protein revealed that its hollow inner core contains many proteins from the AvrE/DspE family. These proteins were found to suppress the plant's immune system and induce dark water-soaked spots on leaves, the telltale signs of infection. However, armed with this newfound knowledge, the researchers sought to develop a strategy to disarm these proteins and halt their destructive effects. They turned to poly(amidoamine) dendrimers (PAMAM), tiny spherical nanoparticles with precise diameters that can be tailored in the lab. By experimenting with different sizes, they identified a nanoparticle that effectively blocked the water channels formed by the bacterial proteins. Application of nanoparticles in blocking water channels In a remarkable series of experiments, the researchers treated frog eggs engineered to produce the water channel protein with these channel-blocking nanoparticles. The results were astounding—the eggs no longer swelled with water and remained unaffected. Similarly, infected Arabidopsis plants treated with the nanoparticles significantly reduced pathogen concentrations, effectively preventing disease development. This breakthrough discovery offers a glimmer of hope in the battle against plant diseases, which cause immense losses in global food production. Plants are responsible for 80% of the world's food supply, and protecting them from pathogens and pests is crucial for ensuring food security. The team's groundbreaking research on plant pathogens and their harmful proteins opens up new possibilities for combating various plant diseases. The implications of their findings extend far beyond a single crop or disease, offering novel approaches to address a wide range of plant diseases. By understanding the mechanism by which bacterial proteins, such as AvrE and DspE, cause diseases in plants, researchers can now explore strategies to disarm these proteins and prevent their harmful effects. The team discovered that these proteins act as water channels, allowing bacteria to invade plant cells and create a saturated environment that promotes their growth. This insight led to the development of channel-blocking nanoparticles, effectively preventing bacteria from infecting plants and causing disease symptoms. Using precise nanoparticles, such as PAMAM dendrimers, to block plant pathogens' water channels represents a promising avenue for crop protection. Figure 1: this figure shows that PAMAM are very branched polymers that are very small, have a low polydispersity index, and have a lot of active amine functional groups. They have multiple modifiable surface functionalities, facilitating the conjugation of ligands for cancer targeting, imaging, and therapy. PAMAM dendrimers also have solubilisation, high drug encapsulation, and passive targeting ability, contributing to their therapeutic success. Cancer researchers are excited about their potential as drug carriers and non-viral gene vectors, with a focus on diagnostic imaging applications. These nanoparticles can be tailored to specific diameters, allowing for targeted disruption of the bacterial proteins' channels. The nanoparticles effectively render the bacteria harmless by interfering with the proteins' ability to create a moist environment within plant cells. This innovative approach has shown success in combating diseases caused by pathogens like Pseudomonas syringae and Erwinia amylovora . Implications for global food production and food security The potential impact of this research on global food production is immense. Plant diseases result in significant crop losses, amounting to over 10% of global food production annually. This translates to a staggering $220 billion economic loss worldwide. Developing strategies to disarm harmful proteins and protect crops from diseases can mitigate these losses and enhance food security. Furthermore, the team's findings highlight the critical role of plant biology research in addressing global challenges. Plants provide 80% of our food, making their health and protection crucial for sustaining our growing population. By understanding how pathogens infect plants and developing innovative solutions, we can safeguard our food supply and reduce the economic impact of crop diseases. Experimental results and a promising outlook The researchers aim to further investigate the interaction between channel-blocking nanoparticles and bacterial proteins. By visualising the structures and mechanisms involved, they hope to refine their designs and develop even more effective strategies for crop protection. Additionally, artificial intelligence, such as the AlphaFold2 programme, has proven instrumental in predicting the 3D structures of complex proteins. Continued advancements in AI technology will undoubtedly contribute to further breakthroughs in understanding and combating plant diseases. By unravelling the mechanisms by which harmful proteins cause diseases in plants and developing innovative strategies to disarm them, we can protect global food production and enhance food security. The implications of this research extend beyond a single crop or disease, paving the way for novel approaches to combat a wide range of plant diseases and safeguard our agricultural systems. Conclusion The groundbreaking research conducted by biologist Sheng-Yang He and his team offer hope in the fight against plant diseases. By revealing the mechanisms by which harmful proteins cause diseases in plants and developing innovative strategies to disarm them, they have paved the way for novel approaches to combat various plant diseases. This enhances food security and protects global food production, reducing economic losses and ensuring a sustainable future. With continued advancements in artificial intelligence and the development of precise nanoparticles, the possibilities for further breakthroughs in understanding and combating plant diseases are endless. By safeguarding our agricultural systems, we can secure the health of our crops and, ultimately, the well-being of our growing population. The implications of this research extend far beyond agriculture, offering new avenues for addressing global challenges and paving the way for a brighter and more resilient future. Figure 2: this figure shows a working model for the molecular actions of AvrE-family effectors in plants. AvrE-family effectors are water- and solute-permeable channels that change the osmotic and water potential and make an apoplast that is rich in water and nutrients for bacteria to grow in plant tissues that are infected. They can also engage host proteins to modulate AvrE-family channel properties or optimise pathogenic outcomes. Written by Sara Maria Majernikova Related articles: Digital innovation in rural farming / Nanomedicine / Mechanisms of pathogen evasion / Nanocarriers REFERENCE Kinya Nomura, Felipe Andreazza, Jie Cheng, Ke Dong, Pei Zhou, Sheng Yang He. Bacterial pathogens deliver water- and solute-permeable channels to plant cells. Nature , 2023; DOI: 10.1038/s41586-023-06531-5 Project Gallery

In particular the novel zeolitic 2-methylimidazole framework (ZIF-8) MOF has received attention for drug delivery. ZIF-8 is composed of Zn2+ ions and 2-methylimidazole ligands, making a highly crystalline structure. ZIF-8 MOFs are able to deliver  cancer drugs like doxorubicin to tumorous environments as it possesses a pH-sensitive degradation property. ZIF-8’s framework will only degrade in pH 5.0-5.5 which is a cancerous pH environment, and will not degrade in normal human body pH 7.4 Go back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link How metal organic frameworks are used to deliver cancer drugs in the body Last updated: 14/11/24 Published: 20/04/23 Metal ions and organic ligands are able to connect to form metallic organic frameworks on a nanoscale (Nano-MOFs) for cancer drug delivery. Metal Organic Frameworks (MOFs) are promising nanocarriers for the encapsulation of cancer drugs for drug delivery in the body. Cancer affects people globally with chemotherapy remaining the most frequent treatment approach. However, chemotherapy is non-specific, being cytotoxic to patients’ normal DNA cells causing severe side effects. Nanoscale Metal Organic Frameworks (Nano-MOFs) are highly effective for encapsulating cancer drugs for controlled drug delivery, acting as capsules that deliver cancer drugs to only tumorous environments. MOFs are composed of metal ions linked by organic ligands creating a permanent porous network. MOFs are able to form one-, two-, or three-dimensional structures building a coordination network with cross-links. When synthesized MOFs are crystalline compound and can sometimes be observed as a cubic structure when observed on a scanning electron microscope (SEM) image. In particular the novel zeolitic 2-methylimidazole framework (ZIF-8) MOF has received attention for drug delivery. ZIF-8 is composed of Zn2+ ions and 2-methylimidazole ligands, making a highly crystalline structure. ZIF-8 MOFs are able to deliver cancer drugs like doxorubicin to tumorous environments as it possesses a pH-sensitive degradation property. ZIF-8’s framework will only degrade in pH 5.0-5.5 which is a cancerous pH environment, and will not degrade in normal human body pH 7.4 conditions. This increases therapeutic efficacy for the patients having less systemic side effects, an aspect that nanomedicine has been extensively researching. As chemotherapy will damage health DNA cells as well as cancer cells, MOFs will only target cancer cells. Additionally the ZIF-8 MOF has a high porosity property due to the MOFs structures that is able to uptake doxorubicin successfully. Zn2+ is used in the medical field having a low toxicity and good biocompatibility. Overall MOFs and metal-organic molecules are important for the advancement of nanotechnology and nanomedicine. MOFs are highly beneficial for cancer research being a less toxic treatment method for patients. ZIF-8 MOFs are a way forward for biotechnology and pharmaceutical companies that research treatments that are more tolerable for patients. Such research shows the diversity of chemistry as the uses of metals and organic molecules are able to expand to medicine. Written by Alice Davey Related article: Anti-cancer metal compounds

Have you perform the wrong exercises – You must keep revising your exercises and keep upgrading your knowledge about the proper use of equipment, and everything else related to fitness so that you don’t make any mistake in giving your clients the wrong exercises Go back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Examples of negligence in personal training on the impact of physiology Last updated: 14/11/24 Published: 26/01/23 Negligence in personal training is a failure to look after clients to avoid them getting injured while training. There are many ways this can happen, below are some examples of negligence in personal training. Making use of equipment that is defective – Using a defective equipment can easily lead to injury or at least poor exercising form. Trainers should be able to differentiate between effective and defective equipment if they want to avoid negligence in training their clients. In that scenario, the best thing a personal trainer can do is to repair the equipment or replace it with new ones instead of putting a ‘defect’ or ‘out of order’ sign on it. Telling you to lift too much weight – You can’t just tell your clients to lift too much weight without even knowing their capacity, their way of eating and experience from past training. This is irrational and unprofessional, thus neglecting your clients directly which can lead to causing them injuries like muscle tears, muscle strains and even worse, a wrong death. Have you perform the wrong exercises – You must keep revising your exercises and keep upgrading your knowledge about the proper use of equipment, and everything else related to fitness so that you don’t make any mistake in giving your clients the wrong exercises to do that can lead to stopping them from achieving their desired physiques, and fitness goals. Muscle imbalances will occur as well if not done properly. Make you exercise for too long – Exercising for too long can cause excess fatigue and can lead to muscle strains and sprains. Coaches must not let their clients push themselves too far. It may sound cool but it is not really healthy. Everything we do must be done in an appropriate manner to avoid consequences that will harm us. Written by Kushwant Nathoo Related articles: A perspective on well-being / Gentrification in the context of health

Natural substances and their treatment potential Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Using Natural Substances to Tackle Infectious Diseases 14/07/25, 15:11 Last updated: Published: 06/06/23, 17:06 Natural substances and their treatment potential Introduction There is increased concern of antimicrobial resistance, especially when referring to bacteria with superbugs such as Methicillin-resistant Staphylococcus aureus (MRSA) and Carbapenem-resistant Enterobacteriaceae (CRE) as they impact lives globally, mainly through fatalities. Given this predicament, It seems that humanity is losing as a result of this pressing issue. However, it is possible for healthcare professionals to utilise more natural products, which are chemicals made by plants, animals and even microorganisms. This includes resources such as wood and cotton aside from food like milk and cacao. In the context of medicinal treatments, an important justification for using more natural products is because although synthetic or partially synthetic drugs are effective for treating countless diseases, an article found that 8% of hospital admissions in the United States and approximately 100,000 fatalities per year were due to people experiencing unfortunate side effects from these drugs. This article explores three specific natural products, where each have similar and unique health properties that can be harnessed to tackle infectious diseases and its subsequent consequences when left sufficiently unaddressed (i.e. antimicrobial resistance). Honey One of the most famous natural products that has been referenced in various areas of research and has been a food and remedial source for thousands of years is honey. It has properties ranging from antibacterial to antioxidant, suggesting that when honey is applied clinically, they have the potential to stop pathogenic bacteria. For example, honey can protect the gastrointestinal system against Helicobacter pylori , which causes stomach ulcers. In disc diffusion assays, the inhibitive properties of honey were shown when honey samples were evaluated holistically as opposed to its individual ingredients. This implies that the macromolecules in honey (carbohydrates, proteins and lipids) work in unison with other biomolecules, illustrating that honey is a distinctive remedy for preventing bacterial growth. For tackling infectious diseases, particularly against wound infections among others, honey’s medicinal properties provide a lot of applications and because it is a natural product, honey would not present any drastic side effects to a patient upon its administration. Garlic Another natural product that can be effective against microorganisms is garlic because similar to honey, it has antimicrobial and antioxidative compounds. A study judged different garlic phenotypes originating from Greece and discovered that they were beneficial against Proteus mirabilis and Escherichia coli aside from inhibiting Candida albicans and C. kruzei . As for fresh garlic juice (FGJ), it increases the zone of inhibition in various pathogens at 10% and more along with it displaying minimum inhibitory concentrations (MICs) in the 4-16% range. Therefore, garlic in solid or liquid form does show potential as a natural antimicrobial agent, especially against pathogenic bacteria and fungi. With this in mind, it too has multiple applications like honey and should be further studied to best isolate the chemical compounds that could be involved in fighting infectious diseases. Turmeric Curcuma longa (also known as turmeric) is one other natural product with unique properties like garlic and honey, making it a suitable candidate against various microbes. One specific pigment that is part of the ginger family and found in turmeric is curcumin, which can tackle diverse microbes through numerous mechanisms illustrated below in Figure 2 . With this said, curcumin has drawbacks: it is highly hydrophobic, has low bioavailability and quickly breaks down. Although when paired with nanotechnology for delivery into the human body, its clinical applications can be advantageous and an additional observation about curcumin is that it can work collaboratively with other plant derived chemicals to stop antibiotic resistant bacteria. One specific bacterial strain that turmeric can attack is Clostridium difficile, a superbug that causes diarrhoea. A study had 27 strains to measure the MICs of turmeric constituents, particularly curcuminoids and curcumin. The results showed reduced C. difficile growth in the concentration range 4-32 μg/mL. Moreover, they had no negative impacts on the gut microbiome and curcumin had more efficacy in stopping C. difficile toxin production compared to fidaxomicin. Thus, turmeric is efficacious as a natural antimicrobial chemical and with further experimentation (same as honey and garlic), it can be harnessed to prevent infectious diseases besides their impact on human lives. Conclusion Considering the above examples of natural products in this article and others not mentioned, it is clear that they can be powerful in the battle against infectious diseases and the problems associated with them, mainly antimicrobial resistance. They are readily available to purchase in markets and shops at low cost, making them convenient. Moreover, populations in Eastern countries like China and India traditionally have used, and are still using these materials for curing pain and illness. In turn, manufacturing medicines from natural products on a larger scale has the prospect of preventing infectious diseases and even alleviating those that patients currently have. Written by Sam Jarada Related article: Mechanisms of pathogen evasion Project Gallery